DK450985A - Doseringsform med vedligeholdt frigoerelse, baseret paa hoejt plastificerede celluloseethergeler - Google Patents

Doseringsform med vedligeholdt frigoerelse, baseret paa hoejt plastificerede celluloseethergeler Download PDF

Info

Publication number
DK450985A
DK450985A DK450985A DK450985A DK450985A DK 450985 A DK450985 A DK 450985A DK 450985 A DK450985 A DK 450985A DK 450985 A DK450985 A DK 450985A DK 450985 A DK450985 A DK 450985A
Authority
DK
Denmark
Prior art keywords
plastified
eyes
cellulose
highly
dosage form
Prior art date
Application number
DK450985A
Other languages
English (en)
Other versions
DK450985D0 (da
Inventor
Daniel A Alderman
Troy D Wolford
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/658,965 external-priority patent/US4695464A/en
Priority claimed from US06/658,964 external-priority patent/US4678516A/en
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of DK450985D0 publication Critical patent/DK450985D0/da
Publication of DK450985A publication Critical patent/DK450985A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
DK450985A 1984-10-09 1985-10-03 Doseringsform med vedligeholdt frigoerelse, baseret paa hoejt plastificerede celluloseethergeler DK450985A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/658,965 US4695464A (en) 1984-10-09 1984-10-09 Sustained release dosage form based on highly plasticized cellulose ether gels
US06/658,964 US4678516A (en) 1984-10-09 1984-10-09 Sustained release dosage form based on highly plasticized cellulose ether gels

Publications (2)

Publication Number Publication Date
DK450985D0 DK450985D0 (da) 1985-10-03
DK450985A true DK450985A (da) 1986-04-10

Family

ID=27097730

Family Applications (1)

Application Number Title Priority Date Filing Date
DK450985A DK450985A (da) 1984-10-09 1985-10-03 Doseringsform med vedligeholdt frigoerelse, baseret paa hoejt plastificerede celluloseethergeler

Country Status (7)

Country Link
EP (1) EP0177893A3 (da)
KR (1) KR900002672B1 (da)
AU (1) AU592065B2 (da)
BR (1) BR8505021A (da)
CA (1) CA1236009A (da)
DK (1) DK450985A (da)
FI (1) FI853928A7 (da)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8616669D0 (en) * 1986-07-09 1986-08-13 Merk Sharpe & Dohme Ltd Pharmaceutical compositions
DE4015160A1 (de) * 1990-05-11 1991-11-14 Wolff Walsrode Ag Methylhydroxypropylcelluloseether und verfahren zu ihrer herstellung
EP2272536B1 (en) 1996-06-26 2016-05-04 Board of Regents, The University of Texas System Hot-melt extrudable Pharmaceutical formulation
AU3212199A (en) * 1998-03-31 1999-10-18 Scimed Life Systems, Inc. Temperature controlled solute delivery system
HK1040641B (zh) * 1998-11-17 2004-10-08 大正制药株式会社 栓剂
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US7658947B2 (en) 2004-06-25 2010-02-09 Kimberly-Clark Worldwide, Inc. Thermo-gelling composition
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
JP5096736B2 (ja) 2006-12-13 2012-12-12 ユニ・チャーム株式会社 吸収性物品
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
JP5774853B2 (ja) 2008-01-25 2015-09-09 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング 医薬投薬形
MX2010012039A (es) 2008-05-09 2010-11-30 Gruenenthal Gmbh Proceso para la preparacion de una formulacion de polvo intermedia y una forma de dosificacion solida final bajo el uso de un paso de congelacion por rocio.
ES2428938T3 (es) 2009-07-22 2013-11-12 Grünenthal GmbH Forma de dosificación resistente a la manipulación y estabilizada frente a la oxidación
BR112012001547A2 (pt) 2009-07-22 2016-03-08 Gruenenthal Gmbh forma de dosagem farmacêutica extrusada por fusão a quente
CA2808219C (en) 2010-09-02 2019-05-14 Gruenenthal Gmbh Tamper resistant dosage form comprising inorganic salt
CN103179954A (zh) 2010-09-02 2013-06-26 格吕伦塔尔有限公司 包含阴离子聚合物的抗破碎剂型
CA2839123A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
PL2736497T3 (pl) 2011-07-29 2018-01-31 Gruenenthal Gmbh Tabletka odporna na ingerencję, zapewniająca natychmiastowe uwalnianie leku
MX356421B (es) 2012-02-28 2018-05-29 Gruenenthal Gmbh Forma de dosificacion resistente a la manipulacion indebida que comprende un compuesto farmacologicamente activo y un polimero anionico.
PL2838512T3 (pl) 2012-04-18 2018-12-31 Grünenthal GmbH Farmaceutyczna postać dawkowania odporna na niewłaściwe użycie i odporna na uderzeniowe uwalnianie dawki
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX371432B (es) 2013-05-29 2020-01-30 Gruenenthal Gmbh Forma de dosificacion resistente al uso indebido que contiene una o mas particulas.
WO2014191396A1 (en) 2013-05-29 2014-12-04 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
US10624862B2 (en) 2013-07-12 2020-04-21 Grünenthal GmbH Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
WO2015078891A1 (en) 2013-11-26 2015-06-04 Farmaceutici Formenti S.P.A. Preparation of a powdery pharmaceutical composition by means of cryo-milling
US20150320690A1 (en) 2014-05-12 2015-11-12 Grünenthal GmbH Tamper resistant immediate release capsule formulation comprising tapentadol
EP3148512A1 (en) 2014-05-26 2017-04-05 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping
BR112017021475A2 (pt) 2015-04-24 2018-07-10 Gruenenthal Gmbh forma de dosagem resistente à adulteração (tamper) com liberação imediata e resistência contra extração de solvente
CZ308361B6 (cs) * 2015-06-25 2020-06-24 Ing Medical S.R.O. Soustava pro aplikaci účinné látky na enkapsulovaný nosič a způsob její činnosti
CZ308352B6 (cs) * 2015-06-25 2020-06-17 Ing Medical S.R.O. Soustava pro aplikaci účinné látky z jednorázového zásobníku na enkapsulovaný nosič a způsob její činnosti
CZ307805B6 (cs) * 2015-06-25 2019-05-22 Ing Medical S.R.O. Zařízení pro funkcionalizaci vláknitých struktur v lékařství a způsob jeho činnosti
AU2016319203A1 (en) 2015-09-10 2018-02-22 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations
US20200147032A1 (en) 2018-11-14 2020-05-14 Robert K. Prud'homme Dihydromyricetin hot melt extrusion formulations and methods for forming them

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7776275A (en) * 1974-04-11 1976-08-05 Warner Lambert Co Production of base for topical steroids
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
EP0040861B1 (en) * 1979-01-11 1985-04-17 Key Pharmaceuticals, Inc. Polymeric diffusion matrix and method of its preparation
US4318746A (en) * 1980-01-08 1982-03-09 Ipco Corporation Highly stable gel, its use and manufacture
JPS5777617A (en) * 1980-10-20 1982-05-15 Nichiban Co Ltd Plaster for cardiac disease
IE53610B1 (en) * 1981-12-14 1988-12-21 Merck & Co Inc Waterless thixotropic composition
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose

Also Published As

Publication number Publication date
FI853928L (fi) 1986-04-10
CA1236009A (en) 1988-05-03
EP0177893A2 (en) 1986-04-16
BR8505021A (pt) 1986-07-29
KR860003024A (ko) 1986-05-19
FI853928A0 (fi) 1985-10-09
FI853928A7 (fi) 1986-04-10
AU4819985A (en) 1986-04-17
DK450985D0 (da) 1985-10-03
AU592065B2 (en) 1990-01-04
KR900002672B1 (ko) 1990-04-23
EP0177893A3 (en) 1987-07-29

Similar Documents

Publication Publication Date Title
DK450985D0 (da) Doseringsform med vedligeholdt frigoerelse, baseret paa hoejt plastificerede celluloseethergeler
FI843990L (fi) Hyaluronsyra-fraktioner med farmaceutisk aktivitet, foerfarande foer framstaellning daerav samt dessa innehaollande farmaceutiska preparat.
FI885822L (fi) Termoplastiska polyuretaner med hoeg foerglasningstemperatur.
ATE40361T1 (de) 2,2'-iminobisaethanol-derivate.
DE3587828D1 (de) Vernetzbare Polymerzusammensetzung.
DE3584480D1 (de) Vernetzbare polymere zusammensetzung.
FI904687A0 (fi) Termoplastiska formmassor med modifierad slaghaollfasthet, foerfarande foer framstaellning och anvaendning av dessa.
DE3884144D1 (de) Modifiziertes Polyolefinharz.
DE3851825D1 (de) Modifiziertes Polyolefinharz.
NO893524D0 (no) Piperazindioner med psykotrop virkning.
DE3850329D1 (de) Thermoplastische Polymethacrylimidzusammensetzung.
FI861695L (fi) Farmaceutiskt preparat och foerfarande foer administrering daerav.
NO863161D0 (no) Polymersammensetninger med forbedret klarhet.
DK304284D0 (da) Sammensaetning til paafoering paa taeppebagside, fremgangsmaade til fremstilling af sammensaetningen samt taeppe belagt med sammensaetningen
IT217724Z2 (it) Occhiali perfezionati.
DE3480791D1 (de) Vinylphenylbenzimidazol-derivate, deren polymere
FI833292A7 (fi) Piperidiinijohdokset, niiden valmistus ja käyttö.
FI842085A7 (fi) 7-okso-4-tia-1-atsabisyklo/3,2,0/hept-2- eeni- johdannaisia.
FI841819A0 (fi) 4,4'- alkylendipiperidinderivat.
ES274182Y (es) Hembrilla perfeccionada.
ES255785Y (es) Muneco con biberon,perfeccionado
FI841234A0 (fi) 7 -acylamido-3-cefem-4- karboxylsyrafoereningar, foerfarande foer deras framstaellning, dessa foereni foereningar innehaollande farmaceutiska preparat samt anvaendning av de sis sistnaemnda.
FI843676L (fi) 7 -acylamido-3-cefem-4- karboxylsyraestrar, foerfarande foer deras framstaellning, dessa foereningar innehaollande farmaceutiska preparat samt anvaendning av de sistnaemnda.
ES273762Y (es) Panal-braguita infantil, perfeccionado.
NO880560L (no) Preparat med kontrollert frigivelse.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment